| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14, 2021 | IRWD Ironwood Pharmaceuticals Inc | Currie Mark G53 | Director | Sell | 23,571 | $11.59 | $273,187.89 | -4.0% | +8.5% | +1.9% | |
| Jun 11, 2021 | BHC Bausch Health Companies Inc. | Eldessouky Sam | EVP &Chief Financial Officer | Sell | 17,000 | $31.68 | $538,585.50 | -12.7% | -10.1% | -74.8% | |
| Jun 11, 2021 | PCRX Pacira Biosciences, Inc. | Riker Lauren Bullaro76 | Vice President, Finance | Sell | 2,003 | $59.85 | $119,879.55 | -13.6% | -7.1% | -7.8% | |
| Jun 10, 2021 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 240,000 | $233.63 | $56,072,352.46 | - | +9.5% | +29.0% | |
| Jun 10, 2021 | ALKS Alkermes Plc. | Dixon Wendy L | Director | Sell | 25,000 | $25.00 | $625,000.00 | -37.7% | +19.2% | +9.2% | |
| Jun 10, 2021 | BCRX Biocryst Pharmaceuticals Inc | Hutson Nancy J58 | Director | Sell | 23,333 | $16.86 | $393,394.38 | -26.4% | -13.1% | -42.7% | |
| Jun 10, 2021 | ALKS Alkermes Plc. | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sell | 13,500 | $25.00 | $337,500.00 | -15.3% | +19.2% | +9.2% | |
| Jun 10, 2021 | NBIX Neurocrine Biosciences Inc | Lyons Gary A54 | Director | Sell | 10,000 | $100.27 | $1,002,743.00 | -4.5% | -5.7% | -6.2% | |
| Jun 10, 2021 | PCRX Pacira Biosciences, Inc. | Williams Kristen Marie76 | Chief Administrative Officer | Sell | 5,689 | $59.60 | $339,062.85 | -11.1% | -4.0% | -5.8% | |
| Jun 10, 2021 | TAK Takeda Pharmaceutical Co Ltd | Takeda Pharmaceutical Co Ltd70 | 10% Owner | Sell | 3,293 | $35.19 | $115,882.76 | -0.2% | -1.3% | -19.6% | |
| Jun 9, 2021 | ORGO Organogenesis Holdings Inc. | Erani Albert79 | 10% Owner | Sell | 150,000 | $15.31 | $2,296,500.00 | -0.3% | +1.7% | -66.2% | |
| Jun 9, 2021 | ALKS Alkermes Plc. | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sell | 882 | $24.60 | $21,697.20 | -100% | +20.1% | +13.9% | |
| Jun 9, 2021 | ORGO Organogenesis Holdings Inc. | Albert Erani Family Trust Dated 12/29/201270 | 10% Owner | Sell | 150,000 | $15.31 | $2,296,500.00 | -0.3% | +1.7% | -66.2% | |
| Jun 9, 2021 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 10,000 | $0.44 | $4,446.00 | - | - | - | |
| Jun 9, 2021 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 220,000 | $224.93 | $49,484,263.05 | - | +13.1% | +36.1% | |
| Jun 9, 2021 | AMPH Amphastar Pharmaceuticals, Inc. | Zhou Rong59 | EVP, Production Center | Sell | 12,912 | $19.43 | $250,829.22 | -6.8% | -4.5% | +53.3% | |
| Jun 8, 2021 | PCRX Pacira Biosciences, Inc. | Manning Donald C. | Chief Medical Officer | Sell | 2,600 | $61.14 | $158,964.00 | -10.0% | -7.2% | -2.3% | |
| Jun 8, 2021 | TAK Takeda Pharmaceutical Co Ltd | Takeda Pharmaceutical Co Ltd70 | 10% Owner | Sell | 2,364 | $35.05 | $82,853.20 | -0.1% | +1.7% | -15.8% | |
| Jun 8, 2021 | AMPH Amphastar Pharmaceuticals, Inc. | Lee Howard | Director | Sell | 15,827 | $19.30 | $305,449.35 | -5.5% | -3.2% | +97.1% | |
| Jun 8, 2021 | ORGO Organogenesis Holdings Inc. | Albert Erani Family Trust Dated 12/29/201270 | 10% Owner | Sell | 254,612 | $15.87 | $4,041,237.68 | -0.1% | -0.6% | -65.3% | |
| Jun 8, 2021 | ORGO Organogenesis Holdings Inc. | Erani Albert79 | 10% Owner | Sell | 254,612 | $15.87 | $4,041,237.68 | -0.1% | -0.6% | -65.3% | |
| Jun 7, 2021 | AKBA Akebia Therapeutics, Inc. | Gilman Steven C70 | Director | Sell | 4,567 | $3.32 | $15,163.35 | -8.7% | -13.4% | -87.5% | |
| Jun 7, 2021 | ALKS Alkermes Plc. | Anstice David W | Director | Sell | 5,000 | $24.00 | $120,000.00 | -6.4% | +26.3% | +23.2% | |
| Jun 7, 2021 | ALKS Alkermes Plc. | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sell | 13,500 | $24.00 | $324,000.00 | -15.3% | +26.3% | +23.2% | |
| Jun 7, 2021 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 15,827 | $19.34 | $306,038.79 | -17.7% | -3.7% | +112.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.